29 Sept 2026, 09:54
Securities Administration—
MEMMEMPHASYS LIMITED.
Announcement history available from 1 August 2025
Fromto
29 Sept 2026, 09:44
Capital RaisingMS
25 Sept 2026, 09:35
Company UpdateMS
21 Sept 2026, 12:12
Director Interests—
18 Sept 2026, 16:27
Securities Administration—
18 Sept 2026, 16:22
Securities Administration—
18 Sept 2026, 16:18
Securities Administration—
18 Sept 2026, 08:45
Company UpdateMS
8 Sept 2026, 09:01
Presentations—
4 Sept 2026, 11:41
Presentations—
3 Sept 2026, 09:32
Company UpdateMS
2 Sept 2026, 09:30
Securities Administration—
1 Sept 2026, 09:29
Company UpdateMS
31 Aug 2026, 18:47
Company Administration—
31 Aug 2026, 18:43
Financial ResultsMS
28 Aug 2026, 08:40
Company UpdateMS
21 Aug 2026, 17:37
Meetings & Governance—
20 Aug 2026, 08:48
Company UpdateMS
10 Aug 2026, 09:28
Company Update—
5 Aug 2026, 08:44
Company UpdateMS
22 July 2026, 11:09
Securities Administration—
22 July 2026, 11:07
Presentations—
16 July 2026, 09:00
Quarterly ReportsMS
15 July 2026, 12:04
Substantial Holders—
6 July 2026, 16:33
Company Administration—
1 July 2026, 08:48
Company UpdateMS
26 June 2026, 14:57
Securities Administration—
26 June 2026, 14:47
Securities Administration—
25 June 2026, 09:53
Company UpdateMS
24 June 2026, 11:59
Presentations—
23 June 2026, 11:04
Presentations—
18 June 2026, 09:52
Securities Administration—
18 June 2026, 09:52
Capital RaisingMS
16 June 2026, 10:08
Trading Halt / SuspensionMS
16 June 2026, 09:54
Trading Halt / SuspensionMS
16 June 2026, 09:51
Company UpdateMS
1 June 2026, 09:21
Company UpdateMS
27 May 2026, 08:51
Company UpdateMS
25 May 2026, 16:54
Director Interests—
25 May 2026, 16:52
Director Interests—
19 May 2026, 08:41
Company Update—
4 May 2026, 13:31
Company Administration—
17 Apr 2026, 09:27
Quarterly ReportsMS
7 Apr 2026, 09:56
PresentationsMS
2 Apr 2026, 09:08
Company Administration—
20 Mar 2026, 08:30
Company UpdateMS
27 Feb 2026, 10:45
Financial ResultsMS
24 Feb 2026, 08:58
Substantial Holders—
20 Feb 2026, 11:53
Securities Administration—
16 Feb 2026, 11:40
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 29 Sept 2026, 09:54 | Proposed issue of securities - MEM | Securities Administration | — | 06013 | |
| 29 Sept 2026, 09:44 | Memphasys receives A$3.5 million from Peters Investments | Capital Raising | MS | 03022, 06005, 08006, 11001 | |
| 25 Sept 2026, 09:35 | Potential Expedited FDA Pathway to US IVF Market | Company Update | MS | 11001 | |
| 21 Sept 2026, 12:12 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 18 Sept 2026, 16:27 | Notification regarding unquoted securities - MEM | Securities Administration | — | 06021 | |
| 18 Sept 2026, 16:22 | Notification regarding unquoted securities - MEM | Securities Administration | — | 06021 | |
| 18 Sept 2026, 16:18 | Application for quotation of securities - MEM | Securities Administration | — | 06020 | |
| 18 Sept 2026, 08:45 | Memphasys Secures European Felix Agreement | Company Update | MS | 11001 | |
| 8 Sept 2026, 09:01 | Memphasys Investor Webinar Presentation - September 2026 | Presentations | — | 03026 | |
| 4 Sept 2026, 11:41 | Investor Webinar Invite | Presentations | — | 14014 | |
| 3 Sept 2026, 09:32 | Felix Registration Achieved in Turkey, Sales Commence | Company Update | MS | 11001 | |
| 2 Sept 2026, 09:30 | Notification of cessation of securities - MEM | Securities Administration | — | 06027 | |
| 1 Sept 2026, 09:29 | EUR526,500 Nordic Agreement Expands Felix European Footprint | Company Update | MS | 11001 | |
| 31 Aug 2026, 18:47 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 31 Aug 2026, 18:43 | Appendix 4E and 2026 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 28 Aug 2026, 08:40 | Felix Early Thai FDA Approval, Commercial Launch Accelerates | Company Update | MS | 11001 | |
| 21 Aug 2026, 17:37 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 20 Aug 2026, 08:48 | Felix Registration Achieved in Vietnam and Cartridge Order | Company Update | MS | 11001 | |
| 10 Aug 2026, 09:28 | Pivotal Felix Study Receives First Scientific Presentation | Company Update | — | 11001 | |
| 5 Aug 2026, 08:44 | European Commercial Roll-out continues with Poland Agreement | Company Update | MS | 11001 | |
| 22 July 2026, 11:09 | Proposed issue of securities - MEM | Securities Administration | — | 06013 | |
| 22 July 2026, 11:07 | Notice of General Meeting/Proxy Form | Presentations | — | 08004, 08007, 14014, 16001 | |
| 16 July 2026, 09:00 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 15 July 2026, 12:04 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 6 July 2026, 16:33 | Memphasys Enters into Consulting Agreement with Director | Company Administration | — | 12008 | |
| 1 July 2026, 08:48 | Exclusive Thailand Commercialisation Agreement Secured | Company Update | MS | 11001 | |
| 26 June 2026, 14:57 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 26 June 2026, 14:47 | Application for quotation of securities - MEM | Securities Administration | — | 06020 | |
| 25 June 2026, 09:53 | UK Market Entry & Acceleration of Commercial Expansion | Company Update | MS | 11001 | |
| 24 June 2026, 11:59 | Investor Presentation - June 2026 | Presentations | — | 03026 | |
| 23 June 2026, 11:04 | Memphasys Investor Webinar | Presentations | — | 14014 | |
| 18 June 2026, 09:52 | Proposed issue of securities - MEM | Securities Administration | — | 06013 | |
| 18 June 2026, 09:52 | Successful $1.2M Placement and Convertible Note Extended | Capital Raising | MS | 02006, 06003, 09014 | |
| 16 June 2026, 10:08 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 16 June 2026, 09:54 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 16 June 2026, 09:51 | Memphasys Executes Supply Agreement with Monash IVF Group | Company Update | MS | 11001 | |
| 1 June 2026, 09:21 | South-East Asian Commercialization Agreement Secured | Company Update | MS | 11001 | |
| 27 May 2026, 08:51 | ITL Orders 1000 Felix Cartridges Across MENA Markets | Company Update | MS | 11001 | |
| 25 May 2026, 16:54 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 25 May 2026, 16:52 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 19 May 2026, 08:41 | Change of Chair | Company Update | — | 11001, 12017 | |
| 4 May 2026, 13:31 | Updated Securities Trading Policy | Company Administration | — | 14013 | |
| 17 Apr 2026, 09:27 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 7 Apr 2026, 09:56 | Investor Presentation - April 2026 | Presentations | MS | 03026, 14014 | |
| 2 Apr 2026, 09:08 | Memphasys Investor Webinar | Company Administration | — | 12008 | |
| 20 Mar 2026, 08:30 | MENA Orders Secured, Expanded & Operations Unaffected | Company Update | MS | 11001 | |
| 27 Feb 2026, 10:45 | Appendix 4D - Half-year Financial Report - 31 December 2025 | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 24 Feb 2026, 08:58 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 20 Feb 2026, 11:53 | Notification of cessation of securities - MEM | Securities Administration | — | 06027 | |
| 16 Feb 2026, 11:40 | Section 708A Cleansing Statement | Securities Administration | — | 06018 |
1–50 of 120
1 / 3